The Download: Montana's new experimental drug rules

Plus: Anthropic says its AI models hacked external organizations during testing. Montana's plan to become an experimental medical hub just pushed forward As of this week in Montana, biotech companies whose drugs have been through preliminary testing--sometimes in as few as 10 healthy people--can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the company can sell it via experimental treatment clinics, the first of which is likely to be up and running around the end of this year. Montana's latest right-to-try legislation is unique. Access to drugs is theoretically available to anyone who gives informed consent and can pay. Read our story to learn about where this may all be headed.